Saxagliptin + dapagliflozin

Trade Name:

Qtern

Manufacturer/Distributor:

AstraZeneca

Classification:

Oral antihyperglycemic agent

DPP-4 inhibitor

Sodium-glucose contransporter 2 (SGLT2) inhibitor

ATC Class:

A10BD21 - saxagliptin and dapagliflozin

Status:

active

Notice of Compliance (yyyy/mm/dd):

2016/11/22

Date Marketed in Canada (yyyy/mm/dd):

2018/03/20

Presentation:

Tablet: 5 mg saxagliptin + 5 mg dapagliflozin. DIN: 02459175

Tablet: 5 mg saxagliptin + 10 mg dapagliflozin. DIN: 02459183

Comments:

This two component product is for use in combination with metformin as an adjunct to diet and exercise to achieve glycemic control in adults with type 2 diabetes mellitus who are inadequately controlled on metformin and saxagliptin alone, OR already controlled with metformin, saxagliptin and dapagliflozin, as individual components.

Keywords:

dapaglifozin

Keywords:

saxagliptin

Keywords:

diabetes mellitus: type 2

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Chlorpropamide	Apo-chlorpropamide	Antidiabetic agent	2017/02/01
Cilazapril	Inhibace	ACE inhibitor
Cladribine	Mavenclad	Immunosuppressant	2017/11/30
Clindamycin + tretinoin	Biacna	Antimicrobial + keratolytic	2010/04
Clofedanol	Ulone	Antitussive
Colesevelam	Lodalis	Bile acid sequestrant	2012/02/06
Crisaborole	Eucrisa	PDE-4 inhibitor	2018/08/29
Crizotinib	Xalkori	ALK Tyrosine Kinase Inhibitor
Cyclosporine	Restasis	Topical immunomodulator with anti-inflammatory effects	2010/10
Daclatasvir	Daklinza	Antiviral agent	2015/09/08
Dacomitinib	Vizimpro	Tyrosine kinase inhibitor	2019/04/22
Dapgliflozin	Forxiga	Sodium-glucose contransporter 2 (SGLT2) inhibitor	2016/02/10
Dapgliflozin + metformin	Xigduo	Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin	2016/02/08
Dapsone	Aczone	Anti-acne therapy	2011/10/21
Daratumumab	Darzalex SC	Antineoplastic agent, monoclonal antibody	2020/08/12
Darolutamide	Nubeqa	Anti-androgen	2020/03/24
Darunavir	Prezista	Antiviral agent	2006
Degarelix	Firmagon	Antineoplastic agent	2009/11
Denosumab	Prolia	RANK Ligand inhibitor	2010/08/10
Denosumab	Xgeva	Bone resorption inhibitor	2011/10/05
Desogestrel + ethinyl estradiol	Apri	Oral contraceptive	2009-03-18
Desonide	Verdeso	Corticosteroid	2011/04/20
Desvenlafaxine	Pristiq	Antidepressant	2009/03/02
Dexamethasone	Ozurdex	Corticosteroid	2012/01/19
Dexlansoprazole	Dexilant	Proton pump inhibitor	2010/07/26
Dexmedetomidine	Precedex	Alpha-2 adrenergic agonist	2010/02/24
Diclofenac potassium	Cambia	NSAID	2012/10
Dienogest	Visanne	Progestin	2011/12/
Difluprednate	Durezol	Topical corticosteroid	2014/03/12
Digoxin	Apo-digoxin; pms-Digoxin; Lanoxin
Digoxin Immune Fab (Ovine)	Digifab	Antidote	2011/12/09
Digoxin Immune Fab (Ovine)	Digibind	Antidote
Dimethyl fumarate	Tecfidera	Misc. central nervous system agent	2013/04
Dimeticone	Nyda	Pediculocide	2012/01/17
Dolasetron mesylate injection	Anzemet	Antiemetic	2011/05/10
Doravirine	Pifeltro	NNRTI	2018/11/15